Mark J. Truty - Publications

Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories.

Journal: ArXiv

Published: June 05, 2026

Liver parenchymal quality stratifies outcomes after hepatic resection for hepatocellular carcinoma.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: April 25, 2026

Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart disease.

Journal: Journal of neuroendocrinology

Published: April 14, 2026

Preoperative Tumor Index Predicts Peritoneal Recurrence after Perioperative Chemotherapy and Resection of Gastric Cancer.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: March 23, 2026

KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.

Journal: Science advances

Published: March 18, 2026

Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: February 16, 2026

Therapeutic targeting of cancer-associated fibroblasts with oncolytic virus in preclinical models of intrahepatic cholangiocarcinoma.

Journal: Molecular therapy. Oncology

Published: February 06, 2026

Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinoma.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center Analysis.

Journal: Annals of surgical oncology

Published: January 27, 2026

Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Longitudinal analysis of matched patient biospecimens reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Long-term cryopreservation reanimation success of pancreatobiliary patient-derived xenograft models.

Journal: Surgery

Published: January 19, 2026